Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023

BUY
$243.35 - $263.81 $28,958 - $31,393
119 New
119 $31,000
Q2 2022

Aug 01, 2022

SELL
$168.06 - $275.16 $70,081 - $114,741
-417 Closed
0 $0
Q1 2022

Apr 22, 2022

BUY
$228.85 - $267.17 $95,430 - $111,409
417 New
417 $105,000
Q2 2019

Jul 24, 2019

SELL
$112.01 - $135.18 $598,693 - $722,537
-5,345 Closed
0 $0
Q1 2019

Apr 26, 2019

SELL
$119.44 - $144.26 $478,954 - $578,482
-4,010 Reduced 42.86%
5,345 $697,000
Q4 2018

Jan 22, 2019

SELL
$116.13 - $146.29 $847,749 - $1.07 Million
-7,300 Reduced 43.83%
9,355 $1.16 Million
Q3 2018

Oct 26, 2018

SELL
$103.19 - $139.12 $430,302 - $580,130
-4,170 Reduced 20.02%
16,655 $2.32 Million
Q2 2018

Jul 19, 2018

BUY
$95.32 - $107.79 $69,107 - $78,147
725 Added 3.61%
20,825 $2.14 Million
Q1 2018

Apr 12, 2018

BUY
$84.96 - $103.9 $1.69 Million - $2.06 Million
19,850 Added 7940.0%
20,100 $1.95 Million
Q4 2017

Jan 23, 2018

BUY
$74.22 - $89.69 $11,207 - $13,543
151 Added 152.53%
250 $22,000
Q3 2017

Oct 13, 2017

BUY
$76.25 - $80.34 $7,548 - $7,953
99
99 $8,000

Others Institutions Holding HCA

About HCA Healthcare, Inc.


  • Ticker HCA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Care Facilities
  • Shares Outstandng 287,024,992
  • Market Cap $103B
  • Description
  • HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surger...
More about HCA
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.